Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Chang-Ji-An Capsule in diarrhea-predominant irritable bowel syndrome
ChiCTR1800017664Phase 2Recruiting
- Sponsor
- Capital Medical University
- Start
- Dec 2017
- Countries
- 1
01
Overview
Phase 2 trial of Changji'an Capsule in Diarrhea-predominant irritable bowel syndrome (IBS-D) (2 arms), sponsored by Capital Medical University. Primary endpoints: Treatment response rate, Abdominal pain response rate and 16 more. Started Dec 2017; status: recruiting.
02
Drugs
Changji'an Capsule
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on ChiCTR1800017664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017664.